Longbio Pharma Presented Positive Topline Phase 1 Results for LP-003 at ERS2023
(Adnkronos) – SOFIA, Bulgaria, June 20, 2023 /PRNewswire/ — Longbio Pharma (Suzhou) Co., Ltd. (abbreviated as “Longbio Pharma”), a pharmaceutical company that develops medicines for the treatment of allergy, asthma, ophthalmology and
